1. Mechanisms of Antimicrobial Resistance

   • Armine M. Sefton

   Current Opinion 16 September 2012 Pages: 557 - 566

   

2. Issues of Adherence to Immunosuppressant Therapy After Solid-Organ Transplantation

   • Marie A. Chisholm

   Leading Article 16 September 2012 Pages: 567 - 575

   

3. Management of Fibromyalgia

   • Karin Ø. Forseth
   • Jan T. Gran

   Therapy in Practice 16 September 2012 Pages: 577 - 592

   

4. Effect of Antiepileptic Drugs on Cognitive Function in Individuals with Epilepsy

   • Lars Brunbech
   • Anne Sabers

   Review Article 16 September 2012 Pages: 593 - 604

   

5. Drugs Affecting Homocysteine Metabolism

   • Cyrus Desouza
   • Maty Keebler
   • Vivian Fonseca

   Review Article 16 September 2012 Pages: 605 - 616

   

6. Drotrecogin Alfa (Activated)

   • Katherine A. Lyseng-Williamson
   • Caroline M. Perry

   Adis New Drug Profile 16 September 2012 Pages: 617 - 630

   

7. Drotrecogin Alfa (Activated)

   • Marcel Levi

   Adis Drug Profile 16 September 2012 Pages: 631 - 631

8. Drotrecogin Alfa (Activated)

   • Derek C. Angus

   Adis Drug Profile 16 September 2012 Pages: 631 - 632

9. Alfuzosin

   • Kate McKeage
   • Greg L. Plosker

   Adis Drug Evaluation 16 September 2012 Pages: 633 - 653

   

10. Paroxetine

    • Antona J. Wagstaff
    • Susan M. Cheer
    • Karen L. Goa

    Adis Drug Evaluation 16 September 2012 Pages: 655 - 703

    

11. Botulinum Toxin B

    • David P. Figgitt
    • Stuart Noble

    Adis Drug Evaluation 16 September 2012 Pages: 705 - 722